Bruker Corporation
BRKRBruker Corporation (BRKR) is a global leader in scientific instrumentation and analytical solutions. It specializes in high-performance tools for molecular and materials research, including mass spectrometry, nuclear magnetic resonance (NMR), and other analytical techniques. The company's products are widely used in healthcare, pharmaceuticals, academia, and industrial research to support scientific discovery and quality control.
Dividend History
Investors can expect a dividend payout of $0.05 per share, scheduled to be distributed in 25 days on January 2, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 2, 2026 | $0.05 | 2025-12-08 | 2025-12-08 |
| October 3, 2025 | $0.05 | 2025-09-23 | 2025-09-23 |
| June 27, 2025 | $0.05 | 2025-06-16 | 2025-06-16 |
| March 28, 2025 | $0.05 | 2025-03-17 | 2025-03-17 |
| December 16, 2024 | $0.05 | 2024-12-02 | 2024-12-02 |
Dividends Summary
- Bruker Corporation has issued 40 dividend payments over the past 10 years
- The most recent dividend was paid 66 days ago, on October 3, 2025
- The highest dividend payed out to investors during this period was $0.05 per share
- The average dividend paid during this period was $0.04 per share.
Company News
Lane Generational, a Massachusetts-based investment advisor, completely sold its $3.6 million stake in Bruker during Q3 2025, exiting all 87,607 shares amid the company's challenging market performance.
The global molecular spectroscopy market is projected to grow from USD 6.97 billion in 2024 to USD 9.04 billion by 2034, driven by expanding healthcare applications, research growth, and technological advancements in drug discovery and diagnostics.
Wall Street indices extended record highs on strong earnings and investor confidence, with gold prices surging to $3,400 amid dollar weakness and speculation about Federal Reserve leadership.
The Instruments - Scientific industry is benefiting from increasing healthcare spending, driven by aging demography, and continued innovation in the pharma and life sciences end markets. Mettler-Toledo and Bruker are gaining from the growing testing needs of newer biological drugs and the increasing demand for automated solutions.
